Gilead Community Collaborations: Working Together to Help End the HIV Epidemic

Gilead Community Collaborations: Working Together to Help End the HIV Epidemic

00:30 |

Related Videos

Gilead slashing prices of top-selling hepatitis C drugs

2:14

Gilead slashing prices of top-selling hepatitis C drugs

Gilead Sciences CEO Daniel O'Day on the collaboration with biotech firm Galapagos

4:48

Gilead Sciences CEO Daniel O'Day on the collaboration with biotech firm Galapagos

30 Days, 30 Countries: Shaming Greedy Gilead Sciences

1:17

30 Days, 30 Countries: Shaming Greedy Gilead Sciences

Founder Stories: John Martin, Former CEO of Gilead Sciences

58:42

Founder Stories: John Martin, Former CEO of Gilead Sciences

How Gilead’s Pharmaceutical Development and Manufacturing Team Delivers Transformative Medicines

3:34

How Gilead’s Pharmaceutical Development and Manufacturing Team Delivers Transformative Medicines

Decades of Achievements: Gilead’s 35th Anniversary

2:43

Decades of Achievements: Gilead’s 35th Anniversary

Daniel O’Day of Gilead Sciences, Inc. on COVID-19 Efforts

0:26

Daniel O’Day of Gilead Sciences, Inc. on COVID-19 Efforts

Gilead Sciences, Inc: A Commitment To Innovation

5:31

Gilead Sciences, Inc: A Commitment To Innovation

Gilead Sciences CEO on raising full-year guidance due to remdesivir sales

2:58

Gilead Sciences CEO on raising full-year guidance due to remdesivir sales

Gilead stock soars on profits from HIV and cancer drugs

1:20

Gilead stock soars on profits from HIV and cancer drugs

San Francisco Community Health Center x Gilead: Helping Increase Access to HIV Care

3:34

San Francisco Community Health Center x Gilead: Helping Increase Access to HIV Care

COMPASS x Gilead HIV: Creating a Culture of Empathy

3:28

COMPASS x Gilead HIV: Creating a Culture of Empathy

Gilead Community Collaborations: Working Together to Help End the HIV Epidemic

0:31

Gilead Community Collaborations: Working Together to Help End the HIV Epidemic

Julie O'Neill, former Vice President & General Manager, Gilead Sciences

2:41

Julie O'Neill, former Vice President & General Manager, Gilead Sciences

Our HIV Anthem: Helping End the HIV Epidemic

5:01

Our HIV Anthem: Helping End the HIV Epidemic

Can Gilead Sciences Maintain Its Dominance in HIV Treatment?

2:44

Can Gilead Sciences Maintain Its Dominance in HIV Treatment?

Zero Hour Ep. 201 “Women Takeover: HIV in Black Women in the U.S.”

35:23

Zero Hour Ep. 201 “Women Takeover: HIV in Black Women in the U.S.”

Gilead Sciences stock surges amid earnings beat and analyst upgrades

1:17

Gilead Sciences stock surges amid earnings beat and analyst upgrades

Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials

6:00

Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials

Gilead’s FOCUS Program Helps Zero In on Early HIV Detection

4:59

Gilead’s FOCUS Program Helps Zero In on Early HIV Detection